NCT02083406View on ClinicalTrials.gov

Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP)

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Malaria
Interventions
DRUG

800mg OZ439 prototype formulation 1

DRUG

800mg OZ439 prototype formulation 2

DRUG

800mg OZ439 prototype formulation 3

DRUG

960mg PQP

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors

Collaborators (1)

Quotient Clinical
All Listed Sponsors
collaborator

Quotient Clinical

OTHER

lead

Medicines for Malaria Venture

OTHER

NCT02083406 - Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP) | Biotech Hunter | Biotech Hunter